Cocaine-induced dendritic spine formation in D1 and D2 dopamine receptor-containing medium spiny neurons in nucleus accumbens

Proceedings of the National Academy of Sciences of the United States of America

Volumn 103, Issue 9, 2006, Pages 3399-3404

  Lee, Ko Woon ^a   Kim, Yong ^a   Kim, Amie M ^a   Helmin, Kathryn ^b   Nairn, Angus C ^a,c   Greengard, Paul ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; TRANSCRIPTION FACTOR FOSB;

ADDICTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; COCAINE DEPENDENCE; CONTROLLED STUDY; DENDRITIC SPINE; DOPAMINE RELEASE; DOSE TIME EFFECT RELATION; DRUG WITHDRAWAL; LONG TERM EXPOSURE; MOUSE; NOCICEPTION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY; REGULATORY MECHANISM;

ANIMALS; CELL PROLIFERATION; COCAINE; DENDRITIC SPINES; GENE EXPRESSION REGULATION; MICE; MICE, TRANSGENIC; NUCLEUS ACCUMBENS; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2;

ANIMALIA; MUS MUSCULUS;

EID: 33644748177     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0511244103     Document Type: Article

References (64)

1. Totterdell, S. & Smith, A. D. (1989) J. Chem. Neuroanat. 2, 285-298.
2. Smith, Y., Bevan, M. D., Shink, E. & Bolam, J. P. (1998) Neuroscience 86, 353-387.
3. Heikkila, R. E., Orlansky, H. & Cohen, G. (1975) Biochem. Pharmacol. 24, 847-852.
4. Ritz, M. C., Lamb, R. J., Goldberg, S. R. & Kuhar, M. J. (1987) Science 237, 1219-1223.
5. Nestler, E. J. (2004) Trends Pharmacol. Sci. 25, 210-218.
6. Kalivas, P. W. & Stewart, J. (1991) Brain Res. Rev. 16, 223-244.
7. Pierce, R. C. & Kalivas, P. W. (1997) Brain Res. Rev. 25, 192-216.
8. Robinson, T. E. & Berridge, K. C. (2003) Annu. Rev. Psychol. 54, 25-53.
9. Wolf, M. E. & Khansa, M. R. (1991) Brain Res. 562, 164-168.
10. Vanderschuren, L. J. & Kalivas, P. W. (2000) Psychopharmacology 151, 99-120.
11. Sesack, S. R. & Pickel, V. M. (1992) J. Comp. Neurol. 320, 145-160.
12. Smith, A. D. & Bolam, J. P. (1990) Trends Neurosci. 13, 259-265.
13. Sibley, D. R. & Monsma, F. J., Jr. (1992) Trends Pharmacol. Sci. 13, 61-69.
14. Beckstead, R. M. & Cruz, C. J. (1986) Neuroscience 19, 147-158.
15. Gerfen, C. R. & Young, W. S., III (1988) Brain Res. 460, 161-167.
16. Gerfen, C. R. (2000) Trends Neurosci. 23, S64-S70.
17. Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., Jr., & Sibley, D. R. (1990) Science 250, 1429-1432.
18. Zahm, D. S. (2000) Neurosci. Biobehav. Rev. 24, 85-105.
19. Lu, X.-Y., Ghasemzadeh, M. B. & Kalivas, P. W. (1998) Neuroscience 82, 767-780.
20. Koob, G. F., Le, H. T. & Creese, I. (1987) Neurosci. Lett. 79, 315-320.
21. Woolverton, W. L. & Virus, R. M. (1989) Pharmacol. Biochem. Behav. 32, 691-697.
22. Bergman, J., Kamien, J. B. & Spealman, R. D. (1990) Behav. Pharmacol. 1, 355-363.
23. Epping-Jordan, M. P., Markou, A. & Koob, G. F. (1998) Brain Res. 784, 105-115.
24. Caine, S. B., Negus, S. S., Mello, N. K. & Bergman, J. (1999) J. Pharmacol. Exp. Ther. 291, 353-360.
25. De Vries, T. J., Cools, A. R. & Shippenberg, T. S. (1998) NeuroReport 9, 1763-1768.
26. Self, D. W., Barnhart, W. J., Lehman, D. A. & Nestler, E. J. (1996) Science 271, 1586-1589.
27. Khroyan, T. V., Barrett-Larimore, R. L., Rowlett, J. K. & Spealman, R. D. (2000) J. Pharmacol. Exp. Ther. 294, 680-687.
28. Alleweireldt, A. T., Weber, S. M., Kirschner, K. F., Bullock, B. L. & Neisewander, J. L. (2002) Psychopharmacology 159, 284-293.
29. Nestler, E. J. (2001) Nat. Rev. Neurosci. 2, 119-128.
30. Robinson, T. E. & Kolb, B. (2004) Neuropharmacology 47, 33-46.
31. Kalivas, P. W. (2004) Curr. Opin. Pharmacol. 4, 23-29.
32. Hyman, S. E. & Malenka, R. C. (2001) Nat. Rev. Neurosci. 2, 695-703.
33. Robinson, T. E. & Kolb, B. (1997) J. Neurosci. 17, 8491-8497.
34. Robinson, T. E. & Kolb, B. (1999) Eur. J. Neurosci. 11, 1598-1604.
35. Li, Y., Kolb, B. & Robinson, T. E. (2003) Neuropsychopharmacology 28, 1082-1085.
36. Gong, S., Zheng, C., Doughty, M. L., Losos, K., Didkovsky, N., Schambra, U. B., Nowak, N. J., Joyner, A., Leblane, G., Hatten, M. E., et al. (2003) Nature 425, 917-925.
37. Zhou, F. M., Wilson, C. J. & Dani, J. A. (2002) J. Neurobiol. 53, 590-605.
38. Grutzendler, J., Tsai, J. & Gan, W. B. (2003) Methods 30, 79-85.
39. Kelz, M. B., Chen, J., Carlezon, W. A., Jr., Whisler, K., Gilden, L., Beckmann, A. M., Steffen, C., Zhang, Y. J., Marotti, L., Self, D. W., et al. (1999) Nature 401, 272-276.
40. Nestler, E. J. (2004) Neuropharmacology 47, 24-32.
41. Le Moine, C. & Bloch, B. (1995) J. Comp. Neurol. 355, 418-426.
42. Surmeier, D. J., Song, W. J. & Yan, Z. (1996) J. Neurosci. 16, 6579-6591.
43. Nye, H. E., Hope, B. T., Kelz, M. B., Iadarola, M. & Nestler, E. J. (1995) J. Pharmacol. Exp. Ther. 275, 1671-1680.
44. Gerfen, C. R., Keefe, K. A. & Gauda, E. B. (1995) J. Neurosci. 15, 8167-8176.
45. Moratalla, R., Elibol, B., Vallejo, M. & Graybiel, A. M. (1996) Neuron 17, 147-156.
46. Badiani, A., Oates, M. M., Day, H. E., Watson, S. J., Akil, H. & Robinson, T. E. (1999) Behav. Brain. Res. 103, 203-209.
47. Uslaner, J., Badiani, A., Norton, C. S., Day, H. E., Watson, S. J., Akil, H. & Robinson, T. E. (2001) Eur. J. Neurosci. 13, 1977-1983.
48. Huff, R. M., Chio, C. L., Lajiness, M. E. & Goodman, L. V. (1998) Adv. Pharmacol. 42, 454-457.
49. Zachariou, V., Sgambato-Faure, V., Sasaki, T., Svenningsson, P., Berton, O., Fienberg, A. A., Nairn, A. C., Greengard, P. & Nestler, E. J. (August 3, 2005) Neuropsychopharmacology, 10.1038/sj.npp.1300832.
50. McClung, C. A. & Nestler, E. J. (2003) Nat. Neurosci. 6, 1208-1215.
51. Norrholm, S. D., Bibb, J. A., Nestler, E. J., Ouimet, C. C., Taylor, J. R. & Greengard, P. (2003) Neuroscience 116, 19-22.
52. Bibb, J. A., Chen, J., Taylor, J. R., Svenningsson, P., Nishi, A., Snyder, G. L., Yan, Z., Sagawa, Z. K., Ouimet, C. C., Nairn, A. C., et al. (2001) Nature 410, 376-380.
53. Nikolic, M., Chou, M. M., Lu, W., Mayer, B. J. & Tsai, L. H. (1998) Nature 395, 194-198.
54. Kesavapany, S., Lau, K. F., McLoughlin, D. M., Brownlees, J., Ackerley, S., Leigh, P. N., Shaw, C. E. & Miller, C. C. (2001) Eur. J. Neurosci. 13, 241-247.
55. Morabito, M. A., Sheng, M. & Tsai, L. H. (2004) J. Neurosci. 24, 865-876.
56. Futter, M., Uematsu, K., Bullock, S. A., Kim, Y., Hemmings, H. C., Jr., Nishi, A., Greengard, P. & Nairn, A. C. (2005) Proc. Natl. Acad. Sci. USA 102, 3489-3494.
57. Hayashi, M. L., Choi, S. Y., Rao, B. S., Jung, H. Y., Lee, H. K., Zhang, D., Chattarji, S., Kirkwood, A. & Toncgawa, S. (2004) Neuron 42, 773-787.
58. Murase, S., Mosser, E. & Schuman, E. M. (2002) Neuron 35, 91-105.
59. Prange, O. & Murphy, T. H. (2001) J. Neurosci. 21, 9325-9333.
60. Feng, J., Yan, Z., Ferreira, A., Tomizawa, K., Liauw, J. A., Zhuo, M., Allen, P. B., Ouimet, C. C. & Greengard, P. (2000) Proc. Natl. Acad. Sci. USA 97, 9287-9292.
61. Li, Y., Acerbo, M. J. & Robinson, T. E. (2004) Eur. J. Neurosci. 20, 1647-1654.
62. Perrotti, L. I., Bolanos, C. A., Choi, K. H., Russo, S. J., Edwards, S., Ulery, P. G., Wallace, D. L., Self, D. W., Nestler, E. J. & Barrot, M. (2005) Eur. J. Neurosci. 21, 2817-2824.
63. Harris, K. M., Jensen, F. E. & Tsao, B. (1992) J. Neurosci. 12, 2685-2705.
64. Vanderklish, P. W. & Edelman, G. M. (2002) Proc. Natl. Acad. Sci. USA 99, 1639-1644.